MAXCYTE, INC. - Equity (MXCT)

CUSIP: 57777K106

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 6 signals
Share change
-264,248
SEC-reported price per share
$4.73
Number of holders
100
Value change
-$12,469,260
Number of buys
57
Number of sells
43
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
103,886,440

Security key

57777K106

Report period

Q2 2022

Institutions

100

Top holders

10

Ownership snapshot

Top reported holders of MXCT - MAXCYTE, INC. - Equity (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Casdin Capital, LLC
Disclosed value leader
Casdin Capital, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $97,660,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Casdin Capital, LLC has the largest disclosed position value at $97.66M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Casdin Capital, LLC's linked filing trail.
Disclosed position value Top 5
Casdin Capital, LLC $97.66M
BlackRock Finance, Inc. $38.05M
BAMCO INC /NY/ $32.14M
Vitruvian Partners LLP $30.66M
D1 Capital Partners L.P. $24.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Casdin Capital, LLC
13F
Company
13F
—
denominator unverified
$97,660,000
13,971,334 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$38,052,000
5,443,837 shares
— 31 Mar 2022
BAMCO INC /NY/
13F
Company
13F
—
denominator unverified
$32,145,000
4,598,669 shares
— 31 Mar 2022
Vitruvian Partners LLP
13F
Company
13F
—
denominator unverified
$30,656,000
4,385,670 shares
— 31 Mar 2022
D1 Capital Partners L.P.
13F
Company
13F
—
denominator unverified
$24,535,000
3,510,000 shares
— 31 Mar 2022
BANK OF MONTREAL /CAN/
13F
Company
13F
—
denominator unverified
$23,267,000
32,025 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
100
Shares
68,054,894
Rows available
100
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2026 Across Filers

Q1 2026 holders
129
Q2 2022 holders
100
Holder diff
-29
Investor Q1 2026 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2026 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .